Nilogen Oncosystems
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3802 Spectrum Blvd Ste 207, Tampa, Flori...Phone Number
(813) 440-3588Website
www.nilogen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nilogen Oncosystems
Nilogen Oncosystems specializes in innovative 3D cancer models using their patented 3D-EXplore technology, which captures tumor heterogeneity from fresh human tumor tissue. Their services cater to oncology applications, including biomarker discovery, cell therapies, and immuno-oncology, providing comprehensive analyses to enhance drug development success. The company aims to improve cancer treatment outcomes by offering insights into therapeutic responses and tumor microenvironments. Their advanced analytical technologies and bioinformatics support clients in making informed decisions for clinical trials and drug development.Explore more
Nilogen Oncosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nilogen Oncosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Nilogen Oncosystems has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nilogen Oncosystems has new funding data
Product Launch: Get notified when Nilogen Oncosystems launches new products
Click to see if Nilogen Oncosystems had a recent Job posting/layoffs
Nilogen Oncosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nilogen Oncosystems recently announced quarterly report
Check out if Nilogen Oncosystems is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Nilogen Oncosystems
Recommended Actions
Find VP level buyers at Nilogen Oncosystems
Find more new buyers
Compare Similar Companies to Nilogen Oncosystems
Compare insights from companies similar to Nilogen Oncosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nilogen Oncosystems is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nilogen Oncosystems is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nilogen Oncosystems.
Nilogen Oncosystems financials insights
Gather financial insights about Nilogen Oncosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$92K
Nilogen Oncosystems Tech Stack
A closer look at the technologies used by Nilogen Oncosystems
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Event
Events
Left Company
Executive Move
Nilogen Oncosystems News & Media
Nilogen Oncosystems Announces Opening of Clinical Trial Using Ex Vivo Tumoroids to Predict Immunotherapy Response in Non-Small Cell Lung Cancer (TUMORIN)
TAMPA, Fla., July 28, 2022 /PRNewswire/ -- Nilogen Oncosystems today announced that its clinical observational study TUMORIN (NCT05332925) has commenced enrolment. Patients with advanced/metastatic NSCLC who are receiving immune checkpoint inhibitors in the standard of care clinical...Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient
Nilogen Oncosystems, a leading Oncology drug development Company, and Scailyte, a single cell AI biomarker discovery company, announced today a s ...Nilogen Oncosystems Announces Partnership with Scailyte AG to Provide Clinically Relevant Translational Platform Supporting Development of Immuno-Oncology Therapeutics in Oncology Clinical Trials and Ultimately to Support Personalized Medicine for Patients
TAMPA, Fla. and BASEL, Switzerland, July 12, 2022 /PRNewswire/ -- Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, a single cell AI biomarker discovery company, announced today a strategic partnership to increase the success rate of novel cancer therapies in...NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial Profiler
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nilogen Oncosystems
Sign Up For FreeTo access detailed company insights
Nilogen Oncosystems specializes in innovative 3D cancer models using their patented 3D-EXplore technology, which captures tumor heterogeneity from fresh human tumor tissue. Their services cater to oncology applications, including biomarker discovery, cell therapies, and immuno-oncology, providing comprehensive analyses to enhance drug development s... Read More
